Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sandu Pharmaceuticals Ltd (NSE: SANDUPHQ), ISIN INE751D01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SANDUPHQ last traded at ₹37.10 (-1.75%), with a 52-week range of ₹30.00 to ₹50.00 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 37.79%, FIIs 0.00%, DIIs 0.01%, mutual funds 0.00%.
EquiSense Score (ECS): 47/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.